Federal Register / Vol. 82, No. 220 / Thursday, November 16, 2017 / Notices 53511 

looking for information about their 

family risk of cancer and genetic 

counseling. Collecting applicant 

information and verifying it annually by 

using the NCI Cancer Genetics Services 

Directory Web-based Application Form 

and Update Mailer is important for 

providing this information to the public 

and for keeping it current. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

180. 

ESTIMATED ANNUALIZED BURDEN HOURS

Form name Type of 

respondent 

Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden 

per response 

(in hours) 

Total annual 

burden hours 

Web-based Application Form ............ Genetics Professional ...................... 60 1 30/60 30 

Web-based Update Mailer ................ Genetics Professional ...................... 600 1 15/60 150 

Totals .......................................... .......................................................... 660 660 ........................ 180 

Dated: November 7, 2017. 

Karla Bailey, 

Project Clearance Liaison, National Cancer 

Institute, National Institutes of Health. 

[FR Doc. 2017–24786 Filed 11–15–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 30-Day 

Comment Request; Generic Clearance 

To Support the Safe To Sleep®

Campaign (Eunice Kennedy Shriver 

National Institute of Child Health and 

Human Development); Correction 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice; correction. 

SUMMARY: The Department of Health and 

Human Services, National Institutes of 

Health published a Notice in the 

Federal Register on November 9, 2017. 

That Notice inadvertently contained an 

error in the SUPPLEMENTARY INFORMATION

section. 

FOR FURTHER INFORMATION CONTACT: Dr. 

Jennifer Guimond, Project Clearance 

Liaison, Office of Science Policy, 

Reporting, and Program Analysis, 

Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, National Institutes of 

Health, 31 Center Drive, Room 2A18, 

Bethesda, Maryland 20892 or call nontoll-free number (301) 496–1877 or 

Email Jennifer.guimond@nih.gov. 

SUPPLEMENTARY INFORMATION: On 

November 9, 2017, the Department of 

Health and Human Services, National 

Institutes of Health published a Notice 

in the Federal Register on page 52062 

(82 FR 52062) that inadvertently did not 

contain the expiration date within the 

SUPPLEMENTARY INFORMATION section 

regarding Proposed Collection:. The 

purpose of this notice is to insert the 

expiration date and should read; 

Proposed Collection: Generic Clearance 

to Support the Safe to Sleep® Campaign 

0925–0701, Expiration Date 07/31/2017, 

REINSTATEMENT WITH CHANGE at 

the Eunice Kennedy Shriver National 

Institute for Child Health and Human 

Development (NICHD), National 

Institutes of Health (NIH). 

Dated: November 9, 2017. 

Jennifer Guimond, 

Project Clearance Liaison, Eunice Kennedy 

Shriver National Institute of Child Health and 

Human Development, National Institutes of 

Health. 

[FR Doc. 2017–24776 Filed 11–15–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 30-Day 

Comment Request; Generic Clearance 

for the Collection of Qualitative 

Feedback on Agency Service Delivery 

(Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development); Correction 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice; correction. 

SUMMARY: The Department of Health and 

Human Services, National Institutes of 

Health published a Notice in the 

Federal Register on November 9, 2017. 

That Notice inadvertently contained an 

error in the SUPPLEMENTARY INFORMATION

section. 

FOR FURTHER INFORMATION CONTACT: Dr. 

Jennifer Guimond, Project Clearance 

Liaison, Office of Science Policy, 

Reporting, and Program Analysis, 

Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, National Institutes of 

Health, 31 Center Drive, Room 2A18, 

Bethesda, Maryland 20892 or call nontoll-free number (301) 496–1877 or 

Email Jennifer.guimond@nih.gov. 

SUPPLEMENTARY INFORMATION: On 

November 9, 2017, the Department of 

Health and Human Services, National 

Institutes of Health published a Notice 

in the Federal Register on page 52067 

(82 FR 52067) that inadvertently 

contained an error in the date of 

expiration. The purpose of this notice is 

to correct the expiration date to read: 

10/31/2017. 

Dated: November 9, 2017. 

Jennifer Guimond, 

Project Clearance Liaison, Eunice Kennedy 

Shriver National Institute of Child Health and 

Human Development, National Institutes of 

Health. 

[FR Doc. 2017–24775 Filed 11–15–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR 16– 


asabaliauskas on DSKBBXCHB2PROD with NOTICES
53512 Federal Register / Vol. 82, No. 220 / Thursday, November 16, 2017 / Notices 

433: Support of NIGMS Program Project 

Grants. 

Date: November 29, 2017. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Eduardo A. Montalvo, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5108, 

MSC 7852, Bethesda, MD 20892, (301) 435– 

1168, montalve@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: AIDS and Related Research. 

Date: December 1, 2017. 

Time: 3:00 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Robert Freund, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5216, 

MSC 7852, Bethesda, MD 20892, 301–435– 

1050, freundr@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

AIDS and AIDS-Related Research. 

Date: December 7, 2017. 

Time: 1:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Robert Freund, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5216, 

MSC 7852, Bethesda, MD 20892, 301–435– 

1050, freundr@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Developmental Abnormalities of the 

Nervous System. 

Date: December 8, 2017. 

Time: 2:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Suzan Nadi, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5217B, 

MSC 7846, Bethesda, MD 20892, 301–435– 

1259, nadis@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR17–031: 

Role of Age-Associated Metabolic Changes in 

Alzheimer’s Disease. 

Date: December 13, 2017. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Alessandra C Rovescalli, 

Ph.D., Scientific Review Officer, National 

Institutes of Health, Center for Scientific 

Review, 6701 Rockledge Drive, Rm. 5205, 

MSC 7846, Bethesda, MD 20892, (301) 435– 

1021, rovescaa@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: November 9, 2017. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–24759 Filed 11–15–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Division of Intramural 

Research Board of Scientific Counselors, 

NIAID. The meeting will be closed to 

the public as indicated below in 

accordance with the provisions set forth 

in section 552b(c)(6), Title 5 U.S.C., as 

amended for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

National Institute of Allergy and 

Infectious Diseases, including 

consideration of personnel 

qualifications and performance, and the 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Division of Intramural 

Research Board of Scientific Counselors, 

NIAID. 

Date: December 11–13, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: National Institutes of Health, 

Building 50, 1227/1233, 50 Center Drive, 

Bethesda, MD 20892. 

Contact Person: Steven M. Holland, MD, 

Ph.D., Chief, Laboratory of Clinical Infectious 

Diseases, National Institutes of Health/ 

NIAID, Hatfield Clinical Research Center, 

Bethesda, MD 20892–1684, 301–402–7684, 

sholland@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: November 9, 2017. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–24761 Filed 11–15–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Prospective Grant of Exclusive Patent 

Commercialization License: Direct 

Reading Detection Kits for Surface 

Contamination by Antineoplastic 

Drugs 

AGENCY: Centers for Disease Control and 

Prevention, National Institutes of 

Health. 

ACTION: Notice. 

SUMMARY: The National Institute of 

Allergy and Infectious Diseases, an 

institute of the National Institutes of 

Health, Department of Health and 

Human Services, on behalf of the 

Centers for Disease Control and 

Prevention, Department of Health and 

Human Services, is contemplating the 

grant of an exclusive patent 

commercialization license to Becton, 

Dickinson and Company, located in 

Franklin Lakes, New Jersey, to practice 

the inventions embodied in the patent 

applications listed in the 

Supplementary Information section of 

this notice. 

DATES: Only written comments and/or 

applications for a license which are 

received by the Technology Transfer 

and Intellectual Property Office, 

National Institute of Allergy and 

Infectious Diseases on or before 

December 1, 2017 will be considered. 

ADDRESSES: Requests for copies of the 

patent applications, inquiries, and 

comments relating to the contemplated 

exclusive patent commercialization 

license should be directed to: Karen 

Surabian, Licensing and Patenting 

Manager, Technology Transfer and 

Intellectual Property Office, National 

Institute of Allergy and Infectious 

Diseases, 5601 Fishers Lane, Suite 2G, 

MSC9804, Rockville, MD 20852–9804, 

phone number 301–594–9719, or 

karen.surabian@nih.gov. 

SUPPLEMENTARY INFORMATION: The 

following represents the intellectual 

property to be licensed under the 

prospective agreement: HHS Reference 

No. E–162–2013/0–US–01, United 

States Provisional Patent Application 

Serial Number 61/672,059, filed 07/16/ 

2012; HHS Reference No. E–162–2013/ 

0–PCT–02, PCT Patent Application 


asabaliauskas on DSKBBXCHB2PROD with NOTICES